Evrofarma SA (ATH:EVROF)
Greece flag Greece · Delayed Price · Currency is EUR
3.830
0.00 (0.00%)
May 11, 2026, 5:10 PM EET

Evrofarma Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
49.4445.7248.7645.3836.7
Revenue Growth (YoY)
8.14%-6.24%7.45%23.66%8.23%
Cost of Revenue
38.9236.9941.739.5932.86
Gross Profit
10.528.737.065.83.84
Selling, General & Admin
6.836.094.644.694.73
Other Operating Expenses
-0.9-1.09-1.24-1.15-1.12
Operating Expenses
5.9353.43.543.61
Operating Income
4.63.733.662.260.23
Interest Expense
-0.65-1.1-1.32-0.84-0.78
Interest & Investment Income
0.04----
Earnings From Equity Investments
--0.060.020.03
Other Non Operating Income (Expenses)
-0.09-0.09-0.07-0.07-0.01
EBT Excluding Unusual Items
3.92.542.321.36-0.54
Gain (Loss) on Sale of Investments
-0-0--0.02
Gain (Loss) on Sale of Assets
0.050.02--0
Asset Writedown
0.580.330.390.160.3
Pretax Income
4.532.892.711.52-0.26
Income Tax Expense
10.610.510.10.1
Net Income
3.532.282.21.42-0.36
Net Income to Common
3.532.282.21.42-0.36
Net Income Growth
54.65%3.54%55.18%--
Shares Outstanding (Basic)
1414141414
Shares Outstanding (Diluted)
1414141414
Shares Change (YoY)
-0.00%-0.03%0.05%-0.02%-
EPS (Basic)
0.260.170.160.10-0.03
EPS (Diluted)
0.260.170.160.10-0.03
EPS Growth
54.65%3.57%55.11%--
Free Cash Flow
-0.514.130.530.6-4.15
Free Cash Flow Per Share
-0.040.300.040.04-0.30
Dividend Per Share
0.0600.0500.050--
Dividend Growth
20.00%----
Gross Margin
21.29%19.10%14.48%12.77%10.46%
Operating Margin
9.29%8.15%7.50%4.97%0.63%
Profit Margin
7.13%4.99%4.52%3.13%-0.97%
Free Cash Flow Margin
-1.03%9.03%1.09%1.32%-11.31%
EBITDA
6.545.495.313.751.63
EBITDA Margin
13.24%12.02%10.89%8.26%4.45%
D&A For EBITDA
1.951.771.661.491.4
EBIT
4.63.733.662.260.23
EBIT Margin
9.29%8.15%7.50%4.97%0.63%
Effective Tax Rate
22.10%21.05%18.66%6.77%-
Advertising Expenses
0.250.20.170.160.12
Source: S&P Global Market Intelligence. Standard template. Financial Sources.